Introduction {#sec1-1}
============

Breast cancer is the most frequently diagnosed cancer among females and a leading cause of death worldwide (Torre et al., 2015). The burden of the disease is progressively shifting from developed to developing countries of Africa, Asia and Latin America, where breast cancer incidence and mortality are increasing (Torre et al., 2015). In Brazil, the estimated risk increased from 52.00 to 56.20 new cases between 2006 and 2016, respectively, per 100,000 women (INCA 2006 and 2016). In North-eastern Brazil, within the same time period of 10 years, the increase of risk from 27.00 to 38.74 new cases per 100,000 women, was more prominent compared to Southern regions of the country (INCA, 2006 and 2016).

Breast cancer is not considered anymore as a single disease, but a heterogeneous group of diseases, with different molecular and cellular characteristics (Rivenbark et al., 2013). Based on global gene expression analysis, four main molecular subtypes were defined (Perou et al., 2000; Sorlie et al., 2001). These molecular subtypes are characterized by the expression status of hormone receptors (HR), estrogen (ER), progesterone (PR) and amplification status of the human epidermal growth factor receptor-2 gene (HER2; Perou et al., 2000; Sorlie et al., 2001). Triple negative breast cancer (TNBC) is characterized by the negative expression status of both HR and it does not exhibit amplification of the HER2 gene (Palma et al., 2015; Joyce et al., 2016; Rody et al., 2017). Due to the lack of therapeutic opportunities and its aggressive nature, characterized by high graded tumours and high relapse rate, TNBC has the worst prognosis and lowest overall survival rate of all molecular subtypes (Palma et al., 2015; Joyce et al., 2016; Rody et al., 2017).

In Brazil, the frequency of TNBC varied between 14.00% and 20.30% in the south-eastern and northern regions, respectively (Carvalho et al., 2014). Two studies have indicated TNBC frequencies of 17.10% and 17.40% in the North-eastern region (Andrade et al., 2014; Carvalho et al., 2014). Most TNBC cases (67.39%) were identified in the group of postmenopausal women aged 50 years or older (Andrade et al., 2014). It is well established in literature that specific reproductive and lifestyle-related factors can increase the risk of TNBC (Redondo et al., 2012; Tamimi et al., 2012; Martinez et al., 2013; Ritte et al., 2013; Ambrosone et al., 2014; Anderson et al., 2014; Nishino et al., 2014; Lambertini et al., 2016; Ma et al., 2017). There are no Brazilian studies about the possible association of lifestyle-related and reproductive risk factors with determined molecular subtypes of breast cancer. Increasing incidence of breast cancer in North-eastern Brazil underlines the importance to understand the association between risk factors and TNBC. The aim of the present study was to identify factors that are heterogeneously associated with chance of TNBC relative to the Luminal A molecular subtype in a population in North-eastern Brazil.

Materials and Methods {#sec1-2}
=====================

Study population {#sec2-1}
----------------

The sampling protocol was reviewed and approved by the Brazilian National Research Ethics Committee (CAAE plataforma Brasil: 22358113.1.0000.5187). Written informed consent was obtained from each participant to participate in this study. Data from breast cancer patients were sampled in two reference centres for breast cancer treatment in the state of Paraíba, North-eastern Brazil: The "Fundação Assistencial da Paraíba" public hospital (FAP) in Campina Grande and the "Hospital Napoleão Laureano" (HNL) in João Pessoa. Both hospitals together treat most breast cancer patients of the state. Patients seeking for treatment may come from regions as far as 600 km from the reference centre. João Pessoa, capital of the state of Paraíba, has about 800.000 inhabitants and is located on the coast (IGBE, 2017). Campina Grande, with about 400.000 inhabitants, the second most populated urban centre in Paraíba, is located about 120 km away from the capital in the inland of the state (IGBE, 2017). Like other states of North-eastern Brazil, Paraíba has mixed-ethnicity population composed of Indigenous, African and European ancestry.

Data sampling {#sec2-2}
-------------

No significant differences were observed between patients of both reference centres. Clinical and histopathological data were obtained from medical records. Molecular subtypes were defined as follows: Luminal A: ER positive (ER+) and/or PR positive (PR+), HER2 negative (HER2-); Luminal B: ER positive (ER+) and/or PR positive (PR+) and HER2 positive (HER2+), HER2 subtype: HER2 positive (HER2+), ER negative (ER−) and PR negative (PR-); Triple negative (TN): ER negative (ER-), PR negative (PR-) and HER2 negative (HER2-). Height and weight were also obtained from medical records. Height and weight had been measured when patients entered the hospital, before any therapeutic treatment. Body mass index (BMI) was defined according to the World Health Organization (WHO, 2015): Underweight: \< 18.5 kg/m^2^; normal weight: 18.5-- 24.99 kg/m^2^; overweight: 25.0--29.99 kg/m2; obesity ≥ 30.0 kg/m^2^.

All data about risk factors with exception of BMI, were obtained by interviewing participants. Interviews were performed within the chemotherapy and radiotherapy units of both hospitals. A questionnaire was developed and tested successfully in a previous case- control study (Almeida et al., 2015). In the present study, a modified version of this original questionnaire was applied. The questionnaire was subdivided into three sections about socio- economic background and life- style related, respectively, reproductive risk factors. Breast cancer patients were interviewed between March 2016 and January 2017.

Recruitment of participants was randomly. Authors asked women directly and explained content and objective of the study. Participation rate varied between 90% and 95% in both hospitals. Time between diagnosis and recruitment was in 72 (30.51%) and 110 (46.61%) cases ≤ 12 and ≤ 24 month, respectively. In 54 (22.88%) cases, it varied between 24 and 36 month. Minimum wage and multiple values were used to characterize income. This is a popular and well-known method to define economic level among low- and middle-class subjects. Information about ethnic origin was obtained by self- information of participating women when asked during the interview.

Participants were eligible if diagnosed within 36 months from recruitment with invasive breast cancer and aged 18 years or older. Of 257 patients, 21 were excluded from the study, because of incomplete information about HR and HER2 expression status. The study included finally 236 patients with invasive operable breast cancer, diagnosed and treated between 2013 and 2016. Of all 236 patients 106 (55.08%) and 130 (44.92%) were from HNL and FAP hospitals, respectively.

Statistical analysis {#sec2-3}
--------------------

ANOVA was applied to compare mean age and mean age of diagnosis. Pearson's Chi-Square (χ^2^) test was applied to compare categorized variables. Molecular subtypes served as dependent variables and categorized data of risk factors as independent variables of regression analysis. Results were presented as adjusted odd ratios (OR), 95% confidence interval (CI) and p-value. P values of regression analysis were calculated using likelihood ratio tests (PLRT). Significant variables of univariate regression analysis were used for regression modelling. To quantify associations between risk factors and TNBC, multiple nominal logistic regression was applied. Luminal A subtype served as reference group. Variables with significance level of PLRT \< 0.2 in the univariate analysis were entered into the model. The final model was tested for fitness using the likelihood ratio test. All statistical analyses were performed using the SPSS STATISTICS™ software (SPPS; IBM company; version 17).

Results {#sec1-3}
=======

The mean age of women was 55.14 (± 12.33) years and 101 (51.80%) out of 236 were married ([Table 1](#T1){ref-type="table"}). Of all women, 35 (15.49%) and 92 (40.71%) informed African and mixed ethnicity, respectively, whereas 99 (43.80%) informed Caucasian ethnicity ([Table 1](#T1){ref-type="table"}). Altogether, 146 (64.03%) women had income of one or less than one minimum wage and 114 (58.46%) had completed elementary school or had no school degree ([Table 1](#T1){ref-type="table"}). The majority of 189 (84.38%) women had no private health insurance ([Table 1](#T1){ref-type="table"}).

###### 

Sociodemographic Characteristics of the 236 Patients

        Mean age (years)   N (%)
  ------------------------ -------------
  Marital status           
   Married                 101 (51.80)
   Single                  53 (27.18)
   Divorced                18 (9.23)
   Widow                   23 (11.79)
   Missing                 41
  Ethnic origin            
   Afro descendent         35 (15.49)
   Caucasian               99 (43.80)
   Mixed ethnicity         92 (40.71)
   Missing                 10
  Income                   
   No one                  3 (1.32)
   ≤ 1                     146 (64.03)
   2-3                     64 (28.07)
   4-6                     13 (5.70)
   7-10                    2 (0.88)
   Missing                 8
  Health insurance         
   Yes                     35 (15.62)
   No                      189 (84.38)
   Missing                 12
  Education                
   ≤ Elementary school     114 (58.46)
   High school             50 (25.64)
   Colleges                31 (15.90)
   Missing                 41

Overall, 134 (56.78%) tumours were Luminal A, 47 (19.92%) were Luminal B, 38 (16.10%) had TNBC and 17 (7.20%) were HER2 ([Table 2](#T2){ref-type="table"}). There was no significant difference among subtypes and association with mean age of patients and their mean age at diagnosis ([Table 2](#T2){ref-type="table"}).

###### 

Clinical and Histopathological Characteristics of 236 Breast Cancer Patients

                                           Luminal A     Luminal B    HER2+        TNBC         
  ---------------------------------------- ------------- ------------ ------------ ------------ -------
  Mean age (years)                                                                              
                                           55.47 ±1.03   54.11±1.70   53.41±2.72   56.00±2.40   0.817
   Age at diagnosis                        54.42±1.07    52.30±1.70   52.71±2.74   55.32±2.54   0.667
   Age at menarche                         13.27±0.15    13.37±0.29   13.35±0.28   12.29±0.31   0.023
                                           N (%)         N (%)        N (%)        N (%)        
  Parity                                                                                        
   No                                      23 (16.42)    5 (10.64)    1 (5.89)     3 (7.89)     0.303
   Yes                                     112 (83.58)   42 (89.36)   16 (94.11)   35 (92.11)   
  Breastfeeding of parous women (N= 205)                                                        
   No                                      13 (11.61)    8 (19.05)    3 (18.75)    4 (11.43)    0.586
   Yes                                     99 (88.39)    34 (80.95)   13 (81.25)   31 (88.57)   
  Anatomic stage (TNM)                                                                          
   I                                       16 (14.55)    1 (2.78)     1 (8.33)     2 (6.67)     0.493
   II                                      42 (38.18)    12 (33.33)   4 (33.34)    12 (40.00)   
   III                                     40 (36.36)    19 (52.78)   6 (50.00)    15 (50.00)   
   IV                                      12 (10.91)    4 (11.53)    1 (8.33)     1 (3.33)     
   Missing                                 24            11           5            8            
  Tumour grade                                                                                  
   I                                       8 (6.30)      0 (0.00)     0            0            0.021
   II                                      88 (69.29)    28 (63.64)   7 (50.00)    19 (51.35)   
   III                                     31 (24.41)    16 (36.36)   7 (50.00)    18 (48.65)   
   Missing                                 7             3            3            1            
  Histological type                                                                             
   Ductal invasive                         107 (79.85)   43 (91.49)   14 (82.35)   32 (84.21)   0.681
   Lobular invasive                        7 (5.22)      0 (0.00)     0 (0.00)     1 (2.63)     
   Mucinous invasive                       4 (2.99)      0 (0.00)     1 (5.88)     1 (2.63)     
   Others                                  16 (11.94)    4 (8.51)     2 (11.77)    4 (10.53)    

Age at menarche in contrast, was significantly different among subtypes (p= 0.023; [Table 2](#T2){ref-type="table"}). Of 205 parous women, 177 (86.34%) had performed breastfeeding. Parity and breastfeeding did not differ significantly among molecular subtypes (p= 0.303; p= 0.586; [Table 2](#T2){ref-type="table"}). There was no significant difference of anatomic stage or histological type of tumours among subtypes ([Table 2](#T2){ref-type="table"}). Of 38 triple negative tumours, 18 (48.65%) were grade three tumours (p= 0.021; [Table 2](#T2){ref-type="table"}).

Results of univariate and multiple nominal regression analysis were summarized in [Table 3](#T3){ref-type="table"}. In univariate analysis, obesity (OR=2.780; CI 95%:1.00-7.72) and early age at menarche (OR= 3.890; CI 95%: 1.61-9.38), were positively associated with TNBC compared to Luminal A subtype ([Table 3](#T3){ref-type="table"}). In contrast, smoking (OR=0.339; CI 95%: 0.14-0.79) and alcohol consumption (OR=0.567; CI 95%: 0.26-1.23), were negatively associated with TNBC ([Table 3](#T3){ref-type="table"}). A model was formed to evaluate the associations between risk factors and TNBC (p= 0.035; [Table 3](#T3){ref-type="table"}). In the adjusted model of multiple analysis, BMI and smoking remained significant (p= 0.004; p= 0.013): Compared to normal weight and underweight patients, obese and overweight patients were 4.489 (CI 95%: 1.32- 15.28) and 1.340 (CI 95%: 0.38- 4.69) more likely of having TNBC compared to Luminal A subtype ([Table 3](#T3){ref-type="table"}). There was no significant association of obesity and overweight with TNBC if data were stratified by menopause status. Of 74 premenopausal and 158 postmenopausal women with known BMI, 25 (33.78%) and 62 (39.24%), respectively, were obese (p= 0.505). The mean BMI of premenopausal and postmenopausal women with Luminal A subtype breast cancer was 27.63 (±0.812) kg/m2 and 28.28 (±0.503) kg/m2, respectively (p= 0.935). Mean BMI of premenopausal and postmenopausal women with TNBC was 30.40 (±2.015) kg/m^2^ and 30.23 (±1.073) kg/m^2^, respectively (p= 0.935). Compared to the mean BMI of 28.09 kg/m^2^ for women with Luminal A breast cancer, BMI was increased to 30.29 kg/m2 for women with TNBC (p= 0.024). Women who did not perform any physical exercise were 2.843 (CI 95%: 1.06- 7.64) more likely of having TNBC compared to Luminal A subtype ([Table 3](#T3){ref-type="table"}).

###### 

Associations Between Risk Factors and TNBC. Luminal A Served as Reference Group

                                                            Luminal A (N= 134)   TNBC (N= 38)   Odds ratios (OR), confidence intervals (95% CI) and significance level of likelihood ratio tests (PLRT)                                 
  --------------------------------------------------------- -------------------- -------------- --------------------------------------------------------------------------------------------------------- ------- --------------------- -------
  Age categories                                                                                                                                                                                                                        
   20-29                                                    1 (0.75)             2 (5.26)       6.800 (0.59-78.13)                                                                                        0.448                         
   30-39                                                    10 (7.46)            5 (13.16)      1.700 (0.53-5.43)                                                                                                                       
   40-49                                                    38 (28.36)           6 (15.79)      0.537 (0.20-1.41)                                                                                                                       
   ≥ 50                                                     85 (63.43)           25 (65.79)     1                                                                                                                                       
  Ethnic origin                                                                                                                                                                                                                         
   Other one                                                72 (55.38)           19 (54.29)     0.957 (0.45-2.02)                                                                                         0.855                         
   Caucasian                                                58 (44.62)           16 (45.71)     1                                                                                                                                       
  Family history                                                                                                                                                                                                                        
   Yes                                                      92 (70.77)           25 (67.57)     0.861 (0.39-1.88)                                                                                         0.191   0.904 (0.37- 2.23)    0.825
   No                                                       38 (29.23)           12 (32.43)     1                                                                                                                                       
   Missing                                                  4                    1                                                                                                                                                      
  BMI                                                                                                                                                                                                                                   
   Obesity                                                  41 (32.28)           19 (54.29)     2.780 (1.00-7.72)                                                                                         0.033   4.489 (1.32- 15.28)   0.004
   Overweight                                               51 (40.16)           10 (28.57)     1.176 (0.39-3.52)                                                                                                 1.340 (0.38- 4.69)    
   Normal^[4](#t3f4){ref-type="table-fn"}^                  35 (27.56)           6 (17.14)      1                                                                                                                                       
   Missing                                                  7                    3                                                                                                                                                      
  Physical activity                                                                                                                                                                                                                     
   No                                                       79 (58.96)           26 (68.42)     1.508 (0.70-3.24)                                                                                         0.055   2.843 (1.06- 7.64)    0.107
   Yes                                                      55 (41.04)           12 (31.58)     1                                                                                                                                       
  Smoking                                                                                                                                                                                                                               
   Ever                                                     59 (44.03)           8 (21.05)      0.339 (0.14-0.79)                                                                                         0.012   0.249 (0.09- 0.71)    0.013
   Never                                                    75 (55.97)           30 (78.95)     1                                                                                                                                       
  Alcohol consumption                                                                                                                                                                                                                   
   Yes                                                      56 (41.79)           11 (28.95)     0.567 (0.26-1.23)                                                                                         0.041   0.709 (0.28- 1.80)    0.22
   No                                                       78 (58.21)           27 (71.05)     1                                                                                                                                       
  Age at menarche                                                                                                                                                                                                                       
   \< 12                                                    14 (10.61)           12 (31.58)     3.890 (1.61-9.38)                                                                                         0.028   4.235 (1.45- 12.42)   0.069
   ≥ 12                                                     118 (89.39)          26 (68.42)     1                                                                                                                                       
   Missing                                                  2                    0                                                                                                                                                      
  Lifetime Breastfeeding^[3](#t3f3){ref-type="table-fn"}^                                                                                                                                                                               
   ≤ 12                                                     50 (50.51)           17 (54.84)     1.275 (0.49-3.31)                                                                                         0.064   1.210 (0.41- 3.55)    0.128
   13-24                                                    19 (19.19)           6 (19.35)      1.184 (0.35-3.94)                                                                                                 1.240 (0.31- 4.89)    
   \> 24                                                    30 (30.30)           8 (25.81)      1                                                                                                                                       
  Menopausal status                                                                                                                                                                                                                     
   Pre                                                      39 (29.10)           13 (34.21)     1.267 (0.58-2.72)                                                                                         0.906                         
   Post                                                     95 (70.90)           25 (65.79)     1                                                                                                                                       
  Age at menopause                                                                                                                                                                                                                      
   \< 50                                                    58 (61.05)           13 (52.00)     0.691 (0.28-1.67)                                                                                         0.931                         
   ≥ 50                                                     37(38.95)            12 (48.00)     1                                                                                                                                       
  Age at first life birth                                                                                                                                                                                                               
   \< 20                                                    33 (28.95)           13 (37.14)     1.838 (0.45-7.47)                                                                                         0.291                         
   20-29                                                    67 (58.77)           19 (54.29)     1.323 (0.34-5.09)                                                                                                                       
   ≥ 30                                                     14 (12.28)           3 (8.57)       1                                                                                                                                       
  Reproductive period^[2](#t3f2){ref-type="table-fn"}^                                                                                                                                                                                  
   ≤ 5                                                      29 (32.23)           8 (30.77)      0.713 (0.25-1.99)                                                                                         0.459                         
   6-10                                                     30 (33.33)           6 (23.08)      0.517 (0.17-1.55)                                                                                                                       
   ≥ 11                                                     31 (34.44)           12 (46.15)     1                                                                                                                                       
  Number of children                                                                                                                                                                                                                    
   0                                                        22 (16.42)           3 (7.89)       0.409 (0.10-1.54)                                                                                         0.345                         
   1-2                                                      61 (45.52)           18 (47.37)     0.885 (0.41-1.89)                                                                                                                       
   \> 2                                                     51 (38.06)           17 (44.74)     1                                                                                                                                       
  Oral contraceptive use                                                                                                                                                                                                                
   Yes                                                      88 (66.17)           23 (60.53)     0.784 (0.37-1.64)                                                                                         0.124   0.664 (0.25- 1.75)    0.804
   No                                                       45 (33.83)           15 (39.47)     1                                                                                                                                       
   Missing                                                  1                    0                                                                                                                                                      

Adjusted for age categories and menopause status;

Between first and last full term pregnancy in years;

Total lifetime breastfeeding of parous women in months;

Including two cases of underweight.

Of all 236 women, 95 (40.25%) smoked some time in their lives. Smoking was negatively associated with TNBC: Women who smoked some time in their lives were 4.016 (OR= 0.249; CI 95%: 0.09- 0.71) times less likely of having TNBC compared to Luminal A subtype ([Table 3](#T3){ref-type="table"}). If data were stratified by menopause status, the odds ratio for premenopausal and postmenopausal women who ever smoked was 0.897 (CI 95%: 0.04-18.47; p= 0.268) and 0.203 (CI 95%: 0.06-0.67; p= 0.012), respectively. Results did not indicate significant association between subtype and amount of smoked cigarettes.

Regarding reproductive risk factors, the likelihood of TNBC was 4.235 times higher among women who had menarche \<12 years (CI 95%: 1.45- 12.42; [Table 3](#T3){ref-type="table"}). If data were stratified by menopause status, the odds ratio for premenopausal and postmenopausal women who had menarche \<12 years was 0.956 (CI 95%: 0.03-33.46; p= 0.974) and 6.500 (CI 95%: 1.83-23.07; p= 0.020), respectively.

Discussion {#sec1-4}
==========

To the best of our knowledge, this is the first Brazilian study that associated specific risk factors with molecular subtypes of breast cancer. Data of case- case analysis indicated that lifestyle-related risk factors smoking and obesity were heterogeneously associated with chance of TNBC compared to Luminal A subtype.

Increased BMI is a well- established lifestyle-related risk factor of breast cancer (Yang et al., 2011; Rose et al., 2015; Kerlikowske et al., 2016; Li et al., 2016). It was postulated that overweight and obesity might be associated with adipose tissue inflammation, favouring malignant cell transformation in the breast (Rose et al., 2015). This process can act on breast tissue, regardless of expression of hormone receptors in postmenopausal women (Rose et al., 2015). Present results indicated that obese women were about 4.5 times more likely to have TNBC compared to Luminal A subtype. However, several studies attributed an increased chance of TNBC only to premenopausal women but not to postmenopausal women: A Turkish study that included 3767 breast cancer patients indicated that obese premenopausal women were more likely to have TNBC compared to Luminal A subtype (Sahin et al., 2016). In a study of the Breast Cancer Surveillance Consortium, increased BMI had a positive association with ER- negative breast cancer in pre/perimenopausal women only, but not in postmenopausal women (Kerlikowske et al., 2016). Similarly, a meta-analysis based on 11 original articles indicated an overall positive association between TNBC and obesity, which remained significant only for premenopausal women after stratification based on menopause status (Pierobon and Frankenfeld, 2013). The finding that data of 34 studies indicated an increased risk of TNBC for obese premenopausal women aged ≤ 50 compared to ER+/PR+ tumours, corroborates these results (Yang et al., 2011). Other Chinese studies also indicated that premenopausal obese and overweight women tended to have TNBC, whereas post- menopause status was associated with Luminal subtypes (Chen et al., 2013; Li et al., 2016). Furthermore, in a Norwegian study that included more than 18.000 postmenopausal women, high BMI was associated with luminal but not triple negative subtypes (1Horn et al., 2014). Similarly, a study on African American women has shown that obese postmenopausal patients had a decreased risk of having TNBC and an increased risk of having ER+ breast cancer (Bandera et al., 2015). These results are in contrast to a recent Chinese study, in which the risk of Luminal subtypes and TNBC were both equally positively associated with increased BMI in premenopausal women (Li et al., 2016). In another Chinese study with 444 premenopausal and 290 postmenopausal TNBC patients without stratification for menopause status, overweight and obesity were associated with Luminal A subtype and not to TNBC (Song et al., 2013).

According to the United Nations Organization (UNO), in the years between 2010 and 2014 overweight and obesity increased from 51.10% to 54.10%, respectively, from 17.80% to 20.00% among Brazilian adults (UNO, 2017). Furthermore, according to the Brazilian Society of Obesity and Metabolic Syndrome (ABESO), of all Brazilian women in 2013 aged 18 years or older 24.40% were obese (ABESO, 2013). The latter study emphasized that the frequency of obesity increased with age and is more common among women aged 50 years and older (ABESO, 2013). In the present study, mean BMI of women with TNBC was increased if compared to Luminal A subtype. The positive association of obesity and TNBC was mainly detected among postmenopausal patients aged 50 years and older. In the study population, obesity could therefore exceed its effect on formation of TNBC mainly in postmenopausal women.

Present results indicated that women who did not perform any physical exercise had an increased chance of TNBC. However, physical exercise did not contribute significantly to the model. In a recent study the protective effect of physical exercise was more pronounced for HR+ and HER2+ breast cancer (Lope et al., 2017). This indicates that physical exercise, like BMI and smoking, can also contribute to heterogeneity of risk among molecular subtypes.

A recent meta-analysis, including 44 and 27 retrospective and prospective studies, respectively, indicated a moderate increase of breast cancer risk for women who smoke (Macacu et al., 2015). Present data indicated that women who smoked some time in their lives were 3.8 times more likely of having Luminal A breast cancer compared to TNBC. This result is in agreement with several previous studies: The Carolina Breast Cancer study identified an increased risk of Luminal breast cancer compared to triple negative basal subtype and this effect was more prominent among Afro-American women (Butler et al., 2016). Similarly, a study performed in the metropolitan area of Seattle reported an increased risk of ER+ breast cancer for women who smoked, whereas the risk of TNBC did not increase (Kawai et al., 2014). A recent study of Park and colleagues that included 5791 Afro-American women with breast cancer, reported a positive association of smoking with ER+ breast cancer among postmenopausal women (Park et al., 2016). In contrast, other recent studies did not indicate that cigarette smoking was differentially associated with molecular subtypes: In a Japanese case-control study, no increased risk due to cigarette smoking was found for any subtype (Nishino et al., 2014). Furthermore, in a recent Lithuanian case-control study, passive smoking did not increase the risk of hormone- receptor positive breast cancer compared to other subtypes (Strumylaite et al., 2017). Furthermore, studies also revealed positive associations between Luminal A subtype and smoking duration, respectively, amounts of smoked cigarettes (Kawai et al., 2014; Butler et al., 2016).

Between 2006 and 2015, the number of active smokers in Brazil decreased about 30.70% and in 2015 about 9.00% of all adult women were smoking (Ministério da Saúde, 2015). However, in the present dataset, more than 40.00% of patients smoked some time in their lives and the majority were low-income women. This could mean that the number of active and former smokers is unusually high among breast cancer patients of this study.

Present data indicated that all reproductive risk factors, with the exception of age at menarche, did not increase the chance of TNBC compared to Luminal A breast cancer. On the one hand, this is not in agreement with some previous studies, which associated risk of TNBC differentially with parity and age at first birth (Millikan et al., 2008; Phipps et al., 2011; Li et al., 2013; Martinez et al., 2013). On the other hand, in agreement with present results, most previous studies also did not identify specific associations of TNBC with age at first birth, parity, menopause status and age at menopause (Islam et al., 2012; Redondo et al., 2012; 2Horn et al., 2014; Lambertini et al., 2016; Li et al., 2016; Sisti et al., 2016; Ma et al., 2017).

Multiple regression analysis showed borderline significance of early age at menarche. This could indicate a possible association of TNBC with early age at menarche. This is in contrast to most previous studies that identified early age at menarche as risk factor for Luminal A breast cancer and did not attribute increased risk to TNBC (Song et al., 2013; 2Horn et al., 2014; Song et al., 2014). Furthermore, several studies carried out in China, Japan, Korea, Germany and the USA, indicated a positive association between hormone receptor positive breast cancer and early age at menarche (Setiawan et al., 2009; Xing et al., 2010; Bao et al., 2011; Tamimi et al., 2012; Chung et al., 2013; Ritte et al., 2013; Warner et al., 2013). Alternatively, there may be a real positive association between early age at menarche and TNBC in the population of the present study: Menarche ≤12 years also increased the risk of basal-like breast cancer in the Carolina Breast Cancer study (Millikan et al., 2008). In a study carried out in Atlanta including Afro-American and Caucasian women, Trivers (2009) reported that ER-PR- breast cancer was more frequent among women who had menarche ≤11 years.

In contrast to other reproductive risk factors, which in most cases are neither positively nor negatively associated with TNBC, it is well established in literature that breastfeeding can reduce its risk (Millikan et al., 2008; Phipps et al., 2008; Redondo et al., 2012; Tamimi et al., 2012; 2Horn et al., 2014; Sisti et al., 2016; Ma et al., 2017). Furthermore, breastfeeding reduced the risk of ER- breast cancer of parous women (Li et al., 2013; Ambrosone et al., 2014). Work and colleagues (2014) reported that parity ≥ three children without breastfeeding, was associated with increased frequency of ER-PR- tumours (Work et al., 2014). In contrast, a study of 1041 women with Mexican ancestry indicated that breastfeeding \> 12 month increased the risk of TNBC twice compared to Luminal A breast cancer (Martinez et al., 2013). A recent meta- analysis of 15 studies indicated that breastfeeding had a protective effect on both, TNBC and luminal subtype breast cancer (Lambertini et al., 2016). A recent study performed in North-eastern Brazil indicated that breastfeeding 24 ≥ month decreased the risk of breast cancer (Almeida et al., 2015). However, present data did not indicate a specific protective effect of breastfeeding on TNBC compared to Luminal A subtype. The possibility that a larger dataset could reveal a protective effect of breastfeeding on TNBC in the population of the present study cannot be ruled out.

The present study had several limitations: Participants of the study were from a limited geographic area. Therefore, present results are not necessarily representative for other Brazilian populations. The most severe limitation was the low number of data. This may have obscured associations of risk factors with TNBC, caused a low data resolution and may have also caused biases. Present study did also not include all life style related risk factors. Participants were randomly selected. However, a selection bias, caused by not- participating patients and exclusion of participants with incomplete information about HR and HER2 expression status, cannot be excluded. Furthermore, as time span between diagnosis and recruitment was long, recall bias cannot be excluded, leading to incomplete or false information about risk factors. The study did not include age or time-related and detailed quantitative information about smoking. Furthermore, data sampling did not include information about other important anthropometric measures like central obesity and waist-to-hip ratio.

In Conclusion, present results indicated that smoking and obesity were differentially associated with TNBC and the Luminal A subtype: Obesity was positively associated with TNBC, whereas smoking was negatively associated with TNBC, respectively, if compared to Luminal A subtype. It will be important to elucidate in case control studies if smoking and obesity generally increase the risk of breast cancer in the population of North-eastern Brazil. Data amplification will be necessary to elucidate in more detail the effects of smoking, BMI and a possible protective effect of breastfeeding on molecular subtypes. Data about age at initiation of smoking, time interval of smoking and amounts of smoked cigarettes will be necessary to obtain more detailed information about the association of smoking with Lumina A subtype. It will be also important to include additional anthropomorphic data about central obesity and waist-to-hip ratio. As in Brazil overweight and obesity frequently start at an early age, it will be important to elucidate possible different effects on breast cancer risk of this physical condition at distinct periods of life. It is important to point out that obesity is a growing problem in Brazil not only among adults, but also among children and adolescents. As overweight and obesity are mainly associated with modifiable lifestyle-related behaviour, it is of special interest to understand the association of this risk factor with aggressive TNBC in more detail.
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